Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anal Cancer
Chemoradiotherapy is feasible in anal carcinomas in HIV-positive patients
July 25th, 2005
There is good news for HIV-positive patients with analy carcinomas: High-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy According to recent research from France, "Anal carcinoma, a common disease in HIV-positive patients, is usually treated with chemoradiotherapy. Generally tolerance was poor before the availability of highly active antiretroviral therapies." "We report our experience of treating anal carcinoma in the era of new antiviral drugs. Between 1997 and 2001, nine men on highly active antiretroviral therapies with good immune status before chemoradiotherapy received concomitant chemoradiotherapy...
Source: Health & Medicine Week (2005-07-25)
|
